SRPT:NASDAQ
Sarepta Therapeutics Inc
$16.07
arrow_upward
+0.37%(+0.060) 1D
$15.88
arrow_downward
-1.18% (-0.19)bedtimeAfter hours
Closed: Nov 13, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SRPT...
Open
$16.05
High
$16.22
Low
$15.70
Mkt. cap
1.72B
Avg. vol.
2.56M
Volume
1.33M
52-wk high
$24.68
52-wk low
$14.68
EPS
-$0.13
Beta
0.45
Shares outstanding
107.24M
No. of employees
835
Open
$16.05
High
$16.22
Low
$15.70
Mkt. cap
1.72B
Avg. vol.
2.56M
Volume
1.33M
52-wk high
$24.68
52-wk low
$14.68
EPS
-$0.13
Beta
0.45
Shares outstanding
107.24M
No. of employees
835
News stories
From web sources and news partners
Yahoo Finance
·
2 days ago
Sarepta Therapeutics, Inc. (SRPT) Stock Forecasts
Profile
Sarepta Therapeutics, Inc. is a medical research and drug development company with corporate offices and research facilities in Cambridge, Massachusetts, United States. Incorporated in 1980 as AntiVirals, shortly before going public the company changed its name from AntiVirals to AVI BioPharma soon with stock symbol AVII and in July 2012 changed name from AVI BioPharma to Sarepta Therapeutics and SRPT respectively. As of 2023, the company has four approved drugs. Wikipedia
About Sarepta Therapeutics Inc
CEODouglas S. Ingram
Employees835
Founded1980
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitesarepta.com